| 000 | 01142 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517201235.0 | ||
| 264 | 0 | _c20180321 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1768-3254 | ||
| 024 | 7 |
_a10.1016/j.ejmech.2018.01.085 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aShah, Harshil R | |
| 245 | 0 | 0 |
_aRecent updates for designing CCR5 antagonists as anti-retroviral agents. _h[electronic resource] |
| 260 |
_bEuropean journal of medicinal chemistry _cMar 2018 |
||
| 300 |
_a115-129 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aCCR5 Receptor Antagonists _xchemical synthesis |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Resistance, Viral _xdrug effects |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aReceptors, CCR5 _xmetabolism |
| 700 | 1 | _aSavjani, Jignasa Ketan | |
| 773 | 0 |
_tEuropean journal of medicinal chemistry _gvol. 147 _gp. 115-129 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejmech.2018.01.085 _zAvailable from publisher's website |
| 999 |
_c28068638 _d28068638 |
||